🚀 VC round data is live in beta, check it out!
Mouwasat Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mouwasat and similar public comparables like Aster DM Healthcare, Narayana Health, Kpj Healthcare, Dallah Healthcare and more.
Mouwasat Overview
About Mouwasat
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue.
Founded
1997
HQ
Employees
4.1K
Website
Sectors
Financials (LTM)
EV
$4B
Mouwasat Financials
Mouwasat reported last 12-month revenue of $894M and EBITDA of $303M.
In the same LTM period, Mouwasat generated $379M in gross profit, $303M in EBITDA, and $209M in net income.
Revenue (LTM)
Mouwasat P&L
In the most recent fiscal year, Mouwasat reported revenue of $860M and EBITDA of $306M.
Mouwasat expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $894M | XXX | $860M | XXX | XXX | XXX |
| Gross Profit | $379M | XXX | $363M | XXX | XXX | XXX |
| Gross Margin | 42% | XXX | 42% | XXX | XXX | XXX |
| EBITDA | $303M | XXX | $306M | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 36% | XXX | XXX | XXX |
| EBIT Margin | 26% | XXX | 27% | XXX | XXX | XXX |
| Net Profit | $209M | XXX | $219M | XXX | XXX | XXX |
| Net Margin | 23% | XXX | 26% | XXX | XXX | XXX |
| Net Debt | — | — | $120M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Mouwasat Stock Performance
Mouwasat has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Mouwasat's stock price is $19.27.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | 0.0% | XXX | XXX | XXX | $1.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMouwasat Valuation Multiples
Mouwasat trades at 4.5x EV/Revenue multiple, and 13.1x EV/EBITDA.
EV / Revenue (LTM)
Mouwasat Financial Valuation Multiples
As of April 18, 2026, Mouwasat has market cap of $4B and EV of $4B.
Equity research analysts estimate Mouwasat's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mouwasat has a P/E ratio of 18.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 4.5x | XXX | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | 13.1x | XXX | 13.0x | XXX | XXX | XXX |
| EV/EBIT | 17.0x | XXX | 17.3x | XXX | XXX | XXX |
| EV/Gross Profit | 10.5x | XXX | 11.0x | XXX | XXX | XXX |
| P/E | 18.4x | XXX | 17.6x | XXX | XXX | XXX |
| EV/FCF | 31.3x | XXX | 19.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mouwasat Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Mouwasat Margins & Growth Rates
Mouwasat's revenue in the last 12 month grew by 13%.
Mouwasat's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Mouwasat's rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mouwasat's rule of X is 67% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Mouwasat Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 36% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 46% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 67% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Mouwasat Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Mouwasat | XXX | XXX | XXX | XXX | XXX | XXX |
| Aster DM Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Narayana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Kpj Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Dallah Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Medicover | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mouwasat M&A Activity
Mouwasat acquired XXX companies to date.
Last acquisition by Mouwasat was on XXXXXXXX, XXXXX. Mouwasat acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Mouwasat
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMouwasat Investment Activity
Mouwasat invested in XXX companies to date.
Mouwasat made its latest investment on XXXXXXXX, XXXXX. Mouwasat invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Mouwasat
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mouwasat
| When was Mouwasat founded? | Mouwasat was founded in 1997. |
| Where is Mouwasat headquartered? | Mouwasat is headquartered in Saudi Arabia. |
| How many employees does Mouwasat have? | As of today, Mouwasat has over 4K employees. |
| Who is the CEO of Mouwasat? | Mouwasat's CEO is Nasser Sultan Fahed Al-Subaie. |
| Is Mouwasat publicly listed? | Yes, Mouwasat is a public company listed on Tadawul. |
| What is the stock symbol of Mouwasat? | Mouwasat trades under 4002 ticker. |
| When did Mouwasat go public? | Mouwasat went public in 2009. |
| Who are competitors of Mouwasat? | Mouwasat main competitors are Aster DM Healthcare, Narayana Health, Kpj Healthcare, Dallah Healthcare. |
| What is the current market cap of Mouwasat? | Mouwasat's current market cap is $4B. |
| What is the current revenue of Mouwasat? | Mouwasat's last 12 months revenue is $894M. |
| What is the current revenue growth of Mouwasat? | Mouwasat revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Mouwasat? | Current revenue multiple of Mouwasat is 4.5x. |
| Is Mouwasat profitable? | Yes, Mouwasat is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Mouwasat? | Mouwasat's last 12 months EBITDA is $303M. |
| What is Mouwasat's EBITDA margin? | Mouwasat's last 12 months EBITDA margin is 34%. |
| What is the current EV/EBITDA multiple of Mouwasat? | Current EBITDA multiple of Mouwasat is 13.1x. |
| What is the current FCF of Mouwasat? | Mouwasat's last 12 months FCF is $127M. |
| What is Mouwasat's FCF margin? | Mouwasat's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Mouwasat? | Current FCF multiple of Mouwasat is 31.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.